• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

What Women Really Think About Overactive Bladder Treatments: A Qualitative Meta-Synthesis

by
October 28, 2026
in Health
Reading Time: 3 mins read
0
What Women Really Think About Overactive Bladder Treatments: A Qualitative Meta-Synthesis

What Women Really Think About Overactive Bladder Treatments: A Qualitative Meta-Synthesis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Overactive bladder (OAB) is a common condition that substantially impairs quality of life, yet it remains underreported and undertreated. A new systematic review and meta-synthesis, published in Frontiers in Global Women’s Health, has brought together the qualitative evidence on how women with OAB, their caregivers, and healthcare professionals actually experience and perceive the treatments on offer.

The research team, led by investigators at the University of Medicine and Pharmacy Iuliu Hatieganu in Cluj-Napoca, Romania, searched MEDLINE, Scopus, Google Scholar and CINAHL from inception to January 2026 for qualitative studies exploring treatment experiences among women with OAB, their caregivers, and healthcare professionals. Three reviewers independently screened the studies, extracted data, and performed line-by-line coding. The material was synthesized using thematic synthesis. Methodological quality was assessed with the Critical Appraisal Skills Programme (CASP) checklist, and confidence in the synthesized findings was evaluated using the GRADE-CERQual approach.

Thirteen qualitative studies made it into the final synthesis. From them, the reviewers identified forty-five codes, which they distilled into five analytical themes. The first, and perhaps the most clinically resonant, is the tension between the burden of treatment and the burden of illness.

The second theme is the erosion of trust in the therapeutic alliance, driven by poor communication and unmet expectations.

Third, the reviewers describe a knowledge gap and a desire for agency. Women in the included studies reported unmet informational needs and a preference for shared decision-making. The fourth theme gathers the psychosocial barriers to treatment engagement: stigma, embarrassment, isolation, and emotional distress.

The fifth theme is a preference for low-burden treatments and a resistance to behavioural change. Women favoured convenient therapies and reported difficulty sustaining long-term behavioural interventions.

Taken together, the synthesis concludes that experiences of OAB treatment extend well beyond symptom control. They are shaped by psychosocial burden, healthcare interactions, treatment expectations, and the need for autonomy. The authors suggest that patient-centered communication, shared decision-making, and individualized support may improve treatment engagement, satisfaction, and adherence.

It is worth being clear about what this study is and what it is not. It is a synthesis of qualitative research, designed to surface themes in lived experience and professional perception, not a trial measuring whether any particular intervention works. The thirteen included studies were appraised for methodological quality with CASP, and confidence in the synthesized findings was formally assessed with GRADE-CERQual, but the conclusions describe perceptions and experiences rather than clinical efficacy.

Even so, the implications are pointed. For service designers, the finding that patients prefer low-burden options and struggle with sustained behavioural change argues for support structures that make those programmes easier to maintain. The study appears in the journal’s Quality of Life section, a fitting home for work whose central claim is that quality of life is exactly where OAB care succeeds or fails.

Subject of Research: Qualitative experiences and perceptions of overactive bladder treatment among women, caregivers, and healthcare professionals

Article Title: Perceptions of overactive bladder treatments among women, caregivers, and healthcare professionals: a systematic review and meta-synthesis

Article References: Roman, M. P., Mihu, D., Rus, D., Olaru, N. S., Mihu, C. M., Ciortea, R., Doumouchtsis, S. K., Roman, A., Bucuri, C. E., Ormindean, C. M., Suciu, V. E., Nati, I. D., & Măluțan, A. M. (2026). Perceptions of overactive bladder treatments among women, caregivers, and healthcare professionals: a systematic review and meta-synthesis. Frontiers in Global Women's Health, 7, Article 1974337. https://doi.org/10.3389/fgwh.2026.1974337

Image Credits: AI Generated

DOI: 10.3389/fgwh.2026.1974337

Keywords: overactive bladder, qualitative research, meta-synthesis, systematic review, women's health, patient-centered care, shared decision-making, treatment burden, therapeutic alliance, GRADE-CERQual, thematic synthesis, urology

News Source: Ophelia Keating. (October 28, 2026). What Women Really Think About Overactive Bladder Treatments: A Qualitative Meta-Synthesis. Scienmag.

Tags: GRADE-CERQualmeta-synthesisoveractive bladderpatient-centered carequalitative researchshared decision-makingsystematic reviewthematic synthesistherapeutic alliancetreatment burdenurologywomen's health
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.